Obesity definition for personalised treatment of type 2 diabetes Authors' reply

Affiliations

¹ Division of Endocrinology, Department of Internal Medicine and Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390-9302, USA. Electronic address: ildiko.lingvay@utsouthwestern.edu.
² Department of Medicine (St Vincent's Hospital), University of Melbourne, Melbourne, VIC, Australia; Department of Endocrinology, Austin Health, Melbourne, VIC, Australia.
³ The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, Sao Paulo, Brazil.
⁴ Diabetes Complications Research Centre, Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland; Diabetes Research Centre, Ulster University, Coleraine, UK.

Comment

Ildiko Lingvay et al. Lancet. 2022.

. 2022 Jun 11;399(10342):2189-2190.

doi: 10.1016/S0140-6736(22)00890-X.

¹ Division of Endocrinology, Department of Internal Medicine and Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390-9302, USA. Electronic address: ildiko.lingvay@utsouthwestern.edu.
² Department of Medicine (St Vincent's Hospital), University of Melbourne, Melbourne, VIC, Australia; Department of Endocrinology, Austin Health, Melbourne, VIC, Australia.
³ The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, Sao Paulo, Brazil.
⁴ Diabetes Complications Research Centre, Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland; Diabetes Research Centre, Ulster University, Coleraine, UK.

No abstract available

Comment on

Obesity definition for personalised treatment of type 2 diabetes.
Golubic R, Barber TM, Caleyachetty R. Golubic R, et al. Lancet. 2022 Jun 11;399(10342):2189. doi: 10.1016/S0140-6736(22)00886-8. Lancet. 2022. PMID: 35691320 No abstract available.